Current research status of transarterial therapies for hepatocellular carcinoma

被引:0
作者
Zhou, Mao-Ting [1 ]
Zhang, Peng [1 ]
Mao, Qi [1 ]
Wei, Xiao-Qin [2 ]
Yang, Lin [1 ]
Zhang, Xiao-Ming [1 ]
机构
[1] North Sichuan Med Coll, Intervent Med Ctr, Sci & Technol Innovat Ctr, Dept Radiol,Affiliated Hosp, South Maoyuan Rd, Nanchong 637000, Sichuan, Peoples R China
[2] North Sichuan Med Coll, Sch Med Imaging, Nanchong 637000, Sichuan, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial therapies; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Transarterial embolization; Transarterial radioembolization; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; IMMUNE CHECKPOINT INHIBITORS; RADIOFREQUENCY ABLATION; INFUSION CHEMOTHERAPY; CLINICAL-TRIAL; SORAFENIB; EMBOLIZATION; EFFICACY; SAFETY; TACE;
D O I
10.4251/wjgo.v16.i9.3752
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
With continuous advancements in interventional radiology, considerable progress has been made in transarterial therapies for hepatocellular carcinoma (HCC) in recent years, and an increasing number of research papers on transarterial therapies for HCC have been published. In this editorial, we comment on the article by Ma et al published in the recent issue of the World Journal of Gastrointestinal Oncology: "Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable HCC". We focus specifically on the current research status and future directions of transarterial therapies. In the future, more studies are needed to determine the optimal transarterial local treatment for HCC. With the emergence of checkpoint immunotherapy modalities, it is expected that the results of trials of transarterial local therapy combined with systemic therapy will bring new hope to HCC patients.
引用
收藏
页码:3752 / 3760
页数:10
相关论文
共 90 条
  • [1] Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma A Randomized Trial
    Abou-Alfa, Ghassan K.
    Johnson, Philip
    Knox, Jennifer J.
    Capanu, Marinela
    Davidenko, Irina
    Lacava, Juan
    Leung, Thomas
    Gansukh, Bolorsukh
    Saltz, Leonard B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (19): : 2154 - 2160
  • [2] Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours
    Alregib, Asseel Hisham
    Tan, Hun Yee
    Wong, Yin How
    Kasbollah, Azahari
    Wong, Eng Hwa
    Abdullah, Basri Johan Jeet
    Perkins, Alan Christopher
    Yeong, Chai Hong
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2023, 66 (10) : 308 - 320
  • [3] Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis - Analysis of 48 cases
    Ando, E
    Tanaka, M
    Yamashita, F
    Kuromatsu, R
    Yutani, S
    Fukumori, K
    Sumie, S
    Yano, Y
    Okuda, K
    Sata, M
    [J]. CANCER, 2002, 95 (03) : 588 - 595
  • [4] Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma
    Arai, Hirotaka
    Abe, Takehiko
    Takayama, Hisashi
    Toyoda, Mitsuo
    Ueno, Takashi
    Kakizaki, Satoru
    Sato, Ken
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (06) : 663 - 666
  • [5] Hepatobiliary Cancers, Version 2.2021
    Benson III, Al B.
    D'Angelica, Michael I.
    Abbott, Daniel E.
    Anaya, Daniel A.
    Anders, Robert
    Are, Chandrakanth
    Bachini, Melinda
    Borad, Mitesh
    Brown, Daniel
    Burgoyne, Adam
    Chahal, Prabhleen
    Chang, Daniel T.
    Cloyd, Jordan
    Covey, Anne M.
    Glazer, Evan S.
    Goyal, Lipika
    Hawkins, William G.
    Iyer, Renuka
    Jacob, Rojymon
    Kelley, R. Kate
    Kim, Robin
    Levine, Matthew
    Palta, Manisha
    Park, James O.
    Raman, Steven
    Reddy, Sanjay
    Sahai, Vaibhav
    Schefter, Tracey
    Singh, Gagandeep
    Stein, Stacey
    Vauthey, Jean-Nicolas
    Venook, Alan P.
    Yopp, Adam
    McMillian, Nicole R.
    Hochstetler, Cindy
    Darlow, Susan D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (05): : 541 - 565
  • [6] Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma
    Blanc-Durand, Paul
    Van der Gucht, Axel
    Jreige, Mario
    Nicod-Lalonde, Marie
    Silva-Monteiro, Marina
    Prior, John O.
    Denys, Alban
    Depeursinge, Adrien
    Schaefer, Niklaus
    [J]. ONCOTARGET, 2018, 9 (04) : 4549 - 4558
  • [7] Radioembolization for Treatment of Hepatocellular Carcinoma: Current Evidence and Patterns of Utilization
    Briody, Hayley
    Duong, David
    Yeoh, Sern Wei
    Hodgson, Russell
    Yong, Tuck Leong
    Hannah, Anthony
    Lee, Michael J.
    Leong, Sum
    Maingard, Julian
    Asadi, Hamed
    Kok, Hong Kuan
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (07) : 1200 - 1213
  • [8] Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
    Burrel, Marta
    Reig, Maria
    Forner, Alejandro
    Barrufet, Marta
    Rodriguez de Lope, Carlos
    Tremosini, Silvia
    Ayuso, Carmen
    Llovet, Josep M.
    Isabel Real, Maria
    Bruix, Jordi
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1330 - 1335
  • [9] Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Bzeizi, Khalid I.
    Arabi, Mohammad
    Jamshidi, Negar
    Albenmousa, Ali
    Sanai, Faisal M.
    Al-Hamoudi, Waleed
    Alghamdi, Saad
    Broering, Dieter
    Alqahtani, Saleh A.
    [J]. CANCERS, 2021, 13 (24)
  • [10] CHANG JM, 1994, CANCER, V74, P2449, DOI 10.1002/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO